Literature DB >> 18367739

Hydroxyurea for the treatment of sickle cell anemia.

Orah S Platt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18367739     DOI： 10.1056/NEJMct0708272

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  104 in total

1.  Gas-phase ions of human hemoglobin A, F, and S.

Authors:  Yang Kang; D J Douglas
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-19       Impact factor: 3.109

2.  EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

Authors:  Aline Renneville; Peter Van Galen; Matthew C Canver; Marie McConkey; John M Krill-Burger; David M Dorfman; Edward B Holson; Bradley E Bernstein; Stuart H Orkin; Daniel E Bauer; Benjamin L Ebert
Journal:  Blood       Date:  2015-08-28       Impact factor: 22.113

Review 3.  Hemoglobin research and the origins of molecular medicine.

Authors:  Alan N Schechter
Journal:  Blood       Date:  2008-11-15       Impact factor: 22.113

4.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

5.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

6.  Potential of Three Ethnomedicinal Plants as Antisickling Agents.

Authors:  Ismaila O Nurain; Clement O Bewaji; Jarrett S Johnson; Robertson D Davenport; Yang Zhang
Journal:  Mol Pharm       Date:  2016-12-05       Impact factor: 4.939

Review 7.  The management of sickle cell pain.

Authors:  Robert E Richard
Journal:  Curr Pain Headache Rep       Date:  2009-08

8.  Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.

Authors:  Nancy S Green; Deepa Manwani; Mahvish Qureshi; Karen Ireland; Arpan Sinha; Arlene M Smaldone
Journal:  Pediatr Blood Cancer       Date:  2016-08-30       Impact factor: 3.167

Review 9.  Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine.

Authors:  Min Dong; Patrick T McGann
Journal:  Clin Pharmacol Ther       Date:  2020-10-08       Impact factor: 6.875

10.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.

Authors:  Guillaume Lettre; Vijay G Sankaran; Marcos André C Bezerra; Aderson S Araújo; Manuela Uda; Serena Sanna; Antonio Cao; David Schlessinger; Fernando F Costa; Joel N Hirschhorn; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.